Avion Wealth Novo Cure LTD Transaction History
Avion Wealth
- $382 Million
- Q3 2024
A detailed history of Avion Wealth transactions in Novo Cure LTD stock. As of the latest transaction made, Avion Wealth holds 38 shares of NVCR stock, worth $1,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38
Previous 82
53.66%
Holding current value
$1,129
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$361 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$352 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$235 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$128 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$90 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.12B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...